World Health Organization and Essential Medicines-Reference-Cited by-同舟云学术

World Health Organization and Essential Medicines

Published:2018-05 Issue:5 Volume:107 Page:1261-1262
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Dugani Sagar,Wasan Kishor M.,Kissoon Niranjan

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference9 articles.

1. WHO model list of essential medicines,2017

2. Sustainable Development Knowledge Platform. New York, NY: United Nations. Available at: https://sustainabledevelopment.un.org/?menu=1300. Accessed June 13, 2017.

3. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy;Tanguay;Can J Cardiol,2013

4. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation;Roffi;Eur Heart J,2016

5. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of COVID-19 on the supply chain of essential health commodities: a mixed method study, in Dar es Salaam, Tanzania;Journal of Pharmaceutical Policy and Practice;2023-09-22

2. Protective effects of hydrogen sulfide pretreatment on cyclophosphamide-induced bladder dysfunction in rats via suppression of bladder afferent nerves;Nitric Oxide;2022-10

3. Recommendations on Off-Label Drug Use in Pediatric Guidelines;Frontiers in Pharmacology;2022-06-09

4. Ethnopharmacology for Skin Diseases and Cosmetics during the COVID-19 Pandemic in Lithuania;International Journal of Environmental Research and Public Health;2022-03-29

5. Low-Dose Cyclophosphamide Induces Nerve Injury and Functional Overactivity in the Urinary Bladder of Rats;Frontiers in Neuroscience;2021-10-01